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1. Introduction
　Invasion and metastasis is characteristic feature of 
malignant tumors.  Although the molecular mecha-
nisms underlying metastasis are complex, it is clear 
that tumor cells must move through the extracellular 
matrix（ECM）in order to invade local tissues and 
metastasize to distal sites.  Tumor cells penetrate and 
degrade two major components of the ECM, which differ 
with respect to composition, location and function ; the 
basement membrane（BM）and interstitial connective 
tissue.  The BM is composed of fibronectin（FN） , laminin
（LAM） , type IV collagen（COLL IV）and heparan sulfate 
proteoglycans1.  It is a thin, continuous, sheet-like 
structure that separates specialized tissues, such as the 
epithelium, blood vessels, and nerve system, from the 
underlying interstitial stroma.  The direct interactions 
of tumor cells with the BM proteins are important 
in tumor invasion and metastasis, and have been 
extensively studied2，3.
　Integrins are ubiquitous, heterodimetric transmem-
brane receptors that attach the cell to the ECM and 
anchor the cytoskeleton to the plasma membrane4. 
Integrin receptors mediate cell adhesion, migration, 
and bidirectional signal transduction through interac-
tion with different ECM proteins4，5.  In particular, ECM 
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integrin interaction leads to the reorganization of the 
actin cytoskeleton, initiation of signal transduction 
cascades and coordination of responses to growth 
factors5.  Recent work points to important interactions 
between integrins and cytoskeletal and signaling 
molecules6.
　Adenoid cystic carcinoma（AdCC）is the most common 
malignant tumor of the salivary glands, characterized 
by unique clinical features and behavior7.  All cases of 
AdCC are aggressive, with a high frequency of pain or 
spontaneous nerve paralysis.  Tumor recurrence or 
metastasis two or more years after excision of the 
primary tumor is common.  AdCC often metastasizes to 
distant organs, such as lung, while oral squamous cell 
carcinoma（SCC）has the propensity for lymph node 
metastasis.  Histopathologically, perineural and perivas-
cular spread without a stromal reaction is characteris-
tic of AdCC.  Unlike many malignant tumors, this 
tumor type produces a large amount of ECM, including 
BM proteins.  The ACCS cell line, which is derived from 
a human AdCC, produces a large amount of ECM, 
including FN, LAM and COLL IV in vitro8，9.  ACCS also 
displays the greatest migration response to a fibroblast-
derived motility factor10.  Based on previous clinical and 
histopathological findings, we postulated that BM 
proteins might promote invasive growth of AdCC cells. 
Therefore, we investigate the migration responses of 
AdCC cells to BM proteins.
2. Materials and Methods
1）Cells and culture
　All cell lines used in this study were of human origin. 
The adenoid cystic carcinoma cell lines, ACCS8―10, 
ACC311 which was a kind gift from Dr Saku（Niigata 
University） , and ACCT, were established in Osaka 
University, Shanghai Second Medical University and 
Kyushu University, respectively.  As a control, we used 
four oral squamous cell carcinoma（SCC）lines derived 
from tongue carcinomas, namely NA, Ca9-2212, SCCKN, 
and SCCTF13.  The cell lines established at Showa 
University（NA） , Tokyo Medical and Dental University
（Ca9-22）and Osaka University（SCCKN and SCCTF）. 
Cells lines were maintained in Dulbecco's modified 
Eagle's medium（DME）supplemented with 10％ fetal 
bovine serum（FBS） , and 2 mM L-glutamine in a 5 ％ 
CO2 incubator at 37℃.
2）Antibodies
　The mouse monoclonal antibody（mAb）4-145（anti-
β 1） 14 was kind a gift from Dr Murakami（Osaka 
University, Japan） .  Mouse mAbs TS2/7（anti- α 1） 15 and 
B-5G10（anti- α 4） 16 were kindly provided by Dr Hemler
（Dana-Farber Cancer Institute, Boston, MA） .  A mouse 
mAb 5E8（anti- α 2） 17 was a kind gift from Dr Bankert
（Roswell Park Cancer Institute, Buffalo, NY） .  Mouse 
mAb J143（anti- α 3） 18 was kindly provided by Dr Albino
（Memorial Sloan-Kettering Cancer Center, New York, 
NY） .  Mouse mAbs SG/73（anti- α 4）and KH/33（anti-
 α 5）were kindly provided by Dr Miyake（Tokyo 
University, Japan） .  Rat mAb GOH3（anti- α 6） 19 was 
kindly obtained from Dr Sonnenberg（The Netherlands 
Cancer Institutes） .  Mouse mAbs FB12（anti- α 1）and 
P1E6（anti- α 2）were purchased from Chemicon Inter-
national Inc.（Temecula, CA） .
3）Flow Cytometric（FCM）analysis
　Flow cytometric analysis was performed as described 
previously12.  Cells were harvested in PBS containing 
0.5％ trypsin and 0.02％ EDTA and resuspended in 
DME following centrifugation.  After washing in ice-
cold PBS, 1 × 106 cells were incubated in 100 μ l of 
primary antibody on ice for 30 min, re-washed in ice-
cold PBS, and then incubated in 100 μ l of FITC-
conjugated secondary antibody on ice for 20 min.  The 
cells were again washed in ice-cold PBS, resuspended 
in 0.5-1 ml of PBS and passed through a 70 μ m 
mesh nylon filter to remove aggregates.  Control 
samples were labeled with the secondary antibody. 
Labeled cells were analyzed in a FACScan cytometer
（Becton Dickinson Immunocytometry Systems, San 
Jose, CA）with the same settings for every experiment. 
 Immediately before analysis, 20-40 μ g/ml propidium 
iodide was added to the cells to allow gating out of dead 
cells.
4）Cell motility assay
　The modified Boyden chamber motility assay was 
used to study haptotactic responses to ECM compo-
nents.  Assays were performed in triplicate using 
a Chemotaxicell（Kurabo Co., Osaka, Japan）with a 
8- μ M pore-size Nuclepore polycarbonate filter（8-mm 
diameter） .  The assay, in which migration is mediated 
by a substrate bound attractant,  involves coating the 
underside of the filters by floating them overnight at 
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37℃ on a solution of FN, LAM, or COLL IV diluted to 
the indicated concentration with PBS.  Chambers were 
assembled and serum-free DME containing 0.1％ BSA 
was  placed in the lower compartment.  All filters were 
washed five times with PBS, dried, and placed in the 
chamber so that the side of the filter with the higher 
concentration of protein faced the lower compartment. 
Cells in the logarithmic phase of growth were collected 
using a brief treatment with PBS containing 0.5％ 
trypsin and 0.02％ EDTA and washed with serum free 
DME.  Cells, at a density of 1 × 105 cells/ml in serum-
free DME supplemented with 0.1％ BSA, were placed in 
the upper compartment of the chamber.  In some 
experiments, cells were pre-incubated in serum-free 
DME containing the indicated anti-integrin antibody at 
0℃ for 1 h.  After a 5-h incubation period at 37℃, filters 
were fixed with methanol, stained with Diff-Quick
（Green Cross Co., Osaka, Japan）, and then mounted on 
glass slides.  Cells that had migrated were quantified by 
light microscopy under high power（× 500） .  For each 
triplicate, the number of cells in five randomly chosen 
fields was determined and the counts were averaged.
3. Results
1）Cell migration in response to ECM components
　The haptotactic migration of various cell lines in 
response to ECM components was examined using a 
modified Boyden chamber.　 In the case of ACCS cells, 
all cells migrated across a step-density gradient of 
substratum-bound FN, LAM, or COLL IV（Fig. 1） .  In 
haptotaxis assays with 3 AdCC lines and 4 SCC lines, 
FN, LAM and COLL IV elicited peak responses at 25-
50, 50, and 5μ g/ml, respectively（Fig. 2） .  The potency 
of these ECM proteins in stimulating migration varied 
with the cell line used.  All 3 AdCC cell lines were more 
responsive than the SCC lines, except that the response 
of ACCT cells to FN was similar to that seen with SCC 
lines.  Importantly, the responses of all AdCC cell lines 
to COLL IV were significantly stronger than those of 
SCC cell lines.  In addition, the AdCC responses to 
COLL IV, even when used at a lower concentration 
（5μ g/ml）, were significantly greater than its responses 
to either FN or LAM.  SCCTF and Ca9-22 showed 
higher responses to these ECM components compared 
to the NA and SCCKN cell lines.
2）Integrin expression
　It seems likely that the motility responses of cells to 
ECM are mediated through cell surface　integrins. 
Flow cytometry provides a relative measure of 
cell surface integrin levels.  ACCS cells gave a 
single fluorescence peak in FCM（Fig. 3） . The mean 
fluorescence intensity of each integrin subunit after 
subtracting the fluorescence of cells labeled with second 
antibody alone in FCM was used to evaluate integrin 
expression in individual cell lines（Fig. 4） .  Three AdCC 
cell lines showed levels of integrin subunit expression 
similar to those of oral SCC lines, although the levels of 
each integrin on the surface varied.  All cell lines 
expressed significant levels of β 1, α 2, α 3 and α 6 
integrin but notα 1 andα 4.  The surface levels ofα 2 and
α 3 integrin on the three AdCC cell lines were a little 
higher than on the three SCC cell lines, except in the 
case of Ca9-22 for which higher surface expression 
levels of β 1, α 2, α 3 and α 6 integrin were noted.  The 
levels of α 6 were higher on SCC lines than on AdCC 
lines.  In most cases, low levels of α 5 integrin were 
observed except for ACC3, which had elevated levels of 
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Fig. 1　Haptotactic response of ACCS cells to ECM 
components. The haptotaxis assay was performed 
using modified Boyden chambers. Briefly, poly- 
carbonate filters were pre-coated with the 
indicated concentrations of each ECM, FN（○） , 
LAM（□） , or COLL IV（△） , and placed in the 
chambers with the ECM side facing the lower 
wells. ACCS cells（1 × 105 cells per well）were 
seeded to the upper compartments and incubated 
in serum-free DME containing 0.1％ BSA at 37℃ 
for 5 h. Migratory cells were counted by light 
microscopy under high power（× 500） . The data 
shown represent the mean± standard error（SE）
of the values for triplicate wells.
β 1 andα 5 integrin.
3）Effects of anti-integrin antibodies on hapto-
taxis
　In an attempt to elucidate the identities of the 
integrin subunits responsible for haptotaxis to BM 
proteins, we screened monoclonal antibodies for 
enhanced-motility blocking activities.  Cells were pre-
incubated with various antibodies and assayed for 
haptotaxis（Table 1） .  The haptotaxis of all cells in 
response to BM proteins was greatly inhibited by an 
anti- β 1 mAb（4-145） .  In general, the haptotaxis-
inhibiting properties of the anti-integrin subunit 
antibodies were matrix protein type-specific.  The anti-
α 5 mAb（KH/33）inhibited the haptotaxis of many cell 
lines to FN but not to LAM or COLL IV.  The anti- α 3 
mAb（J143）potently inhibited haptotactic responses of 
many cell lines to LAM, while AdCC haptotaxis to 
laminin was inhibited not only by anti- α 3 but also by 
anti- α 2（P1E6）and anti- α 6（GOH3）antibodies.  The 
enhanced motility of all AdCC cell lines to type IV 
collagen was significantly and exclusively inhibited 
by anti- α 2 integrin antibody（P1E6） .  The similar 
inhibition of type IV collagen-induced motility was 
observed when pre - treated with anti - α 2 integrin 
antibody 5E8 instead of P1E6.
4. Discussion
　AdCC spreads relentlessly into adjacent tissues 
and recurrence and distant metastasis occur fre-
quently7.  In this study, we compared the haptotactic 
responses to BM proteins of AdCC（ACCS, ACC3, and 
ACCT）and SCC cell lines.  Haptotaxis assays showed 
that substratum-bound FN, LAM and COLL IV 
stimulated cell migration, and the AdCC responses, 
especially to COLL IV, were significantly higher than 
those of SCC cells.
　It seems likely that cell haptotaxis to the ECM is 
mediated through cell surface integrins that interact 
with both ECM and cell surface ligands.  Organ-specific 
integrin-mediated interactions between tumor cells and 
the ECM are thought to be important for invasion and 
metastasis.  AdCC is accompanied by high frequencies 
of pain, nerve paralysis, recurrence and metastasis to 
lung, and is characterized by perineural and perivascu-
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Fig. 2　Comparison of motility responses of different 
cells to ECM components. Haptotaxis was 
assayed as described in the legend to Fig. 1. FN 
and LAM were used at a concentration of 50 μ g/ 
ml and COLL IV was at 5μ g/ml. Migratory cells 
were counted by light microscopy under high 
power（× 500） . The data shown represent the 
mean ± standard error（SE）of the values for 
triplicate wells.
Fig. 3　Flow cytometry of ACCS cells stained with anti-
integrin antibodies. Cells were stained with 4-145
（anti- β 1） , TS2/7（anti- α 1） , P1E6（anti- α 2） , J143
（anti- α 3） , SG/73（anti- α 4） , KH/33（anti- α 5） , 
GOH3（anti- α 6） , antibodies or secondary anti- 
body and analyzed as described in the Materials 
and Methods section. Abscissa : logarithm of 
fluorescence intensity ; ordinate axis : relative cell 
number.
lar spread without a stromal reaction7.  The enhanced 
motility responses of AdCC cell lines to COLL IV and 
LAM may be related to a proclivity to invade nerve and 
endothelial sheaths, which consist of BM.  It has been 
proposed that the organ-specific invasion mechanism is 
controlled by specific or strong expression of various 
adhesion molecules, including integrins.  For example, 
it has been demonstrated that the ovarian epithelial 
carcinoma cells adhere preferentially to type I collagen 
in a process mediated by α 2 β 1 integrins and sub- 
sequent secretion of matrix-degrading proteinases may 
facilitate peritoneal dissemination20.  An association 
between the overexpression of α 2 β 1 or α 3 β 1 integrin 
and invasion and metastasis has been observed in many 
tumor types, including malignant melanoma21 and 
breast cancer22.  Three AdCC lines expressed significant 
levels ofβ 1,α 2,α 3, andα 6 integrin, but notα 1 andα 4. 
This corroborates a previous report studying normal 
salivary glands and pleomorphic adenomas, in which 
most of the tumor cells and normal basal and ductal 
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Fig. 4　Fluorescence of different cells labeled with anti-integrin antibodies. The 
indicated cells were stained with 4-145（anti- β 1） , TS2/7（anti- α 1） ,  P1E6
（anti- α 2） ,  J143（anti- α 3） , SG/73（anti- α 4） , KH/33（anti- α 5） , or GOH3
（anti- α 6） , antibodies or second antibody alone. All cell lines gave a 
single peak of fluorescence intensity for each integrin. The mean 
fluorescence values（arbitrary units）were calculated by substracting the 
mean fluorescence of the peak for secondary antibody-labeled cells from 
the mean fluorescence of the peak for anti-integrin labeled cells. 
cells expressed β 1, α 2, α 3, and α 6 integrins23, suggest-
ing that this pattern of integrin expression is normal for 
both salivary gland epithelial cells and their associated 
tumors.  Although AdCC cell lines expressed slightly 
higher levels ofα 2 β 1 andα 3 β 1 integrins than SCC cell 
lines, these differences were not as impressive as those 
seen in haptotaxis assays to ECM proteins, and in 
particular to COLL IV.  Our previous study on SCC cell 
lines failed to demonstrate a relationship between 
increased integrin expression of in vitro and the ability 
to induce metastasis in nude mice12.  However, when 
metastatic SCC cell lines were injected into nude mice, 
increased levels of integrins were seen compared to 
when non-metastatic SCC lines were injected.  Among 
the SCC cell lines examined in this study, SCCTF 
showed the highest motility responses to ECM proteins 
while the SCCTF surface levels of integrins were 
comparable or lower than those on other SCC cell lines. 
SCCTF was previously shown to be metastatic when 
injected into nude mice12.  Our results suggest a 
correlation between motility responses to ECM in vitro 
and the ability to induce metastasis in the nude mouse 
model.
　In previous studies, significant correlation could or 
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Table 1　Inhibitory effects of integrin subunit-specific antibody on 
motility responses of tumor cells to ECM. Haptotaxis of the 
indicated cells were assessed at 50 μ g/ml for FN, 50 μ g/ml for 
LAM, or 5μ g/ml for COLL IV as described in the legend to Fig. 
2.  Before the motility assay, cells were pre-incubated in serum-
free DME containing 4-145（anti- β 1） , FB12（anti- α 1）, P1E6 
（anti- α 2） , J143（anti- α 3） , SG/73（anti- α 4） , KH/33（anti- α 5） , 
GOH3（anti- α 6） , or 0.1％ BSA（control）at 0℃ for 1 h. The 
results of triplicate measurements were calculated as the 
percentages of control motility without antibody, and their 
inhibitory effects are represented as follow :＋＋＋ , greater than 
80％ inhibition ; ＋＋ , greater than 50％ , but less than 80％ , 
inhibition ; ＋ , greater than 20％ , but less than 50％ , inhibition ; 
－ , less than 20％ effect.
anti-integrin antibody
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not be drawn between integrin expression and function. 
The expression of α V β 6 integrin is not detectable on 
normal oral epithelium but is increased significantly in 
oral SCC, and the increased expression in SCC leads to 
an increased capacity for migration24，25.  In some cases, 
compared to normal oral keratinocytes, oral SCC lines 
showed reduced surface integrin expression, but did not 
show in a decrease in the proportion of cells adhering to 
ECM components26，27.  Therefore, the predominant 
invasive and metastatic phenotypes of tumor cells 
cannot simply be explained by the observed overexpres-
sion of single or multiple integrin molecules.  In order to 
elucidate integrin functionality, we performed blocking 
experiments with specific antibodies.  The results 
indicated thatα 2 β 1 andα 3 β 1 integrins mediated AdCC 
cell migration to COLL IV and LAM, respectively.  Most 
importantly, the motility responses of AdCC cells to 
COLL IV were largely and exclusively inhibited by the 
anti- α 2 integrin antibodies.
　Integrin-mediated cell adhesion and motility can be 
regulated not only by altering the repertoire of integrin 
expression on the cell surface but also by modulating 
integrin affinity for ligands.  Integrin affinity for 
extracellular ligands is modulated in response to 
cytoplasmic signals responding to the activation of 
other cellular receptors. The activation of lymphocytes 
and malignant cells with antigen, phorbol esters, 
cytokines（e.g.,TNF- α , IL-1 β）or growth factors（TGF-
β , PDGF, FGFs）leads to up-regulation of integrin 
expression with or without concomitant changes in 
their surface levels22，28―30.  In addition, many works 
suggest that intracellular proteins, such as tyrosine 
kinases, serine/threonine kinases, and phosphatases, 
and members of the small GTPase family such as R-Ras 
and RhoA regulate integrin-mediated events, such as 
cell adhesion and migration31―33.
　In conclusion, the reason why AdCC cells preferen-
tially display high motility responses to COLL IV 
remains unclear.  The results of this study suggest that 
AdCC migration to COLL IV is mainly mediated by 
α 2 β 1 integrin.  However, the levels ofα 2 β 1 integrin on 
the surface of AdCC cells are similar to those on SCC 
cell lines.  It is likely that several mechanisms, 
including integrin-mediated signaling cascades, are 
involved in the invasion and metastasis of AdCC. 
Further work is required to elucidate how ECM-
mediated migration of AdCC cells is regulated. 
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